Localization of metallothionein in urothelial carcinoma of the human urinary bladder: an immunohistochemical study including correlation with HLA-DR antigen, p53, and proliferation indices
dc.contributor.author | Ioachim, E. E. | en |
dc.contributor.author | Charchanti, A. V. | en |
dc.contributor.author | Stavropoulos, N. E. | en |
dc.contributor.author | Athanassiou, E. | en |
dc.contributor.author | Michael, M. C. | en |
dc.contributor.author | Agnantis, N. J. | en |
dc.date.accessioned | 2015-11-24T19:06:33Z | |
dc.date.available | 2015-11-24T19:06:33Z | |
dc.identifier.issn | 0250-7005 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20351 | |
dc.rights | Default Licence | - |
dc.subject | Age Factors | en |
dc.subject | Aged | en |
dc.subject | Antibodies, Monoclonal/metabolism | en |
dc.subject | Carcinoma/*metabolism | en |
dc.subject | Cell Division | en |
dc.subject | Epitopes | en |
dc.subject | Female | en |
dc.subject | HLA-DR Antigens/*biosynthesis | en |
dc.subject | Humans | en |
dc.subject | Immunohistochemistry | en |
dc.subject | Male | en |
dc.subject | Metallothionein/*biosynthesis/chemistry | en |
dc.subject | Middle Aged | en |
dc.subject | Protein Isoforms | en |
dc.subject | Sex Factors | en |
dc.subject | Tumor Suppressor Protein p53/*biosynthesis | en |
dc.subject | Urinary Bladder Neoplasms/*metabolism | en |
dc.subject | Urothelium/*metabolism/pathology | en |
dc.title | Localization of metallothionein in urothelial carcinoma of the human urinary bladder: an immunohistochemical study including correlation with HLA-DR antigen, p53, and proliferation indices | en |
heal.abstract | Metallothionein (MT) is a low-molecular-weight cysteine-rich protein, which has the ability to bind and sequestrate heavy metal ions. Synthesis of MT is induced in a variety of tissues by these metal ions, as well as by endogenous factors such as glucocorticoids, interferon, interleukin-1 and vitamin D. Several lines of evidence show that MT may play a role in carcinogenesis. In this study MT expression was detected immunohistochemically, using a monoclonal antibody (E9) against a conserved epitope of I and II isoforms, in a series of 63 cases of urothelial carcinomas of the urinary bladder. Correlation between MT expression and HLA-DR antigen expression, p53, proliferation indices (PCNA and MIBI) as well as the various clinicopathological parameters, such as age, sex, squamous metaplasia, tumor grade, stage and recurrence were studied. In a semiquantitative analysis MT expression (> 10% of neoplastic cells) was observed in 12.7%, focal MT positivity in 11.1% and almost completely lack of MT expression in 76.2% of tumors. The incidence of MT expression was significantly higher (p=0.0002) in cases with high pathological tumor grades. MT values were significantly correlated with tumor stage (p=0.0009). A statistically significant positive correlation between MT expression and the HLA-DR antigen expression (p=0.001) was also detected. The data suggested that MT expression was correlated with a more aggressive behavior in urothelial bladder cancer. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/11497256 | - |
heal.journalName | Anticancer Res | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2001 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: